These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
362 related items for PubMed ID: 21955665
1. The impact of microscopic disease on the tumor control probability in non-small-cell lung cancer. Siedschlag C, Boersma L, van Loon J, Rossi M, van Baardwijk A, Gilhuijs K, Stroom J. Radiother Oncol; 2011 Sep; 100(3):344-50. PubMed ID: 21955665 [Abstract] [Full Text] [Related]
2. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation. Moreno-Jiménez M, Aristu J, López-Picazo JM, Ramos LI, Gúrpide A, Gómez-Iturriaga A, Valero J, Martínez-Monge R. Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448 [Abstract] [Full Text] [Related]
3. Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets. Haedinger U, Krieger T, Flentje M, Wulf J. Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):239-49. PubMed ID: 15629617 [Abstract] [Full Text] [Related]
4. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. Onishi H, Kuriyama K, Komiyama T, Tanaka S, Sano N, Marino K, Ikenaga S, Araki T, Uematsu M. Lung Cancer; 2004 Jul 01; 45(1):45-55. PubMed ID: 15196734 [Abstract] [Full Text] [Related]
5. Convolution method and CTV-to-PTV margins for finite fractions and small systematic errors. Gordon JJ, Siebers JV. Phys Med Biol; 2007 Apr 07; 52(7):1967-90. PubMed ID: 17374922 [Abstract] [Full Text] [Related]
6. Adequate margins for random setup uncertainties in head-and-neck IMRT. Astreinidou E, Bel A, Raaijmakers CP, Terhaard CH, Lagendijk JJ. Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):938-44. PubMed ID: 15708278 [Abstract] [Full Text] [Related]
7. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume. Admiraal MA, Schuring D, Hurkmans CW. Radiother Oncol; 2008 Jan 01; 86(1):55-60. PubMed ID: 18082905 [Abstract] [Full Text] [Related]
8. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets. Underberg RW, Lagerwaard FJ, Slotman BJ, Cuijpers JP, Senan S. Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):554-60. PubMed ID: 15890600 [Abstract] [Full Text] [Related]
9. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis. Macdonald OK, Kruse JJ, Miller JM, Garces YI, Brown PD, Miller RC, Foote RL. Int J Radiat Oncol Biol Phys; 2009 Nov 01; 75(3):950-8. PubMed ID: 19801106 [Abstract] [Full Text] [Related]
10. Dosimetric effect of respiratory motion in external beam radiotherapy of the lung. Mechalakos J, Yorke E, Mageras GS, Hertanto A, Jackson A, Obcemea C, Rosenzweig K, Clifton Ling C. Radiother Oncol; 2004 May 01; 71(2):191-200. PubMed ID: 15110453 [Abstract] [Full Text] [Related]
11. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP). Jensen I, Carl J, Lund B, Larsen EH, Nielsen J. Med Dosim; 2011 May 01; 36(2):130-7. PubMed ID: 20488692 [Abstract] [Full Text] [Related]
12. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh. Hong L, Alektiar KM, Hunt M, Venkatraman E, Leibel SA. Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):752-9. PubMed ID: 15183478 [Abstract] [Full Text] [Related]
13. Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques. Ong CL, Verbakel WF, Cuijpers JP, Slotman BJ, Lagerwaard FJ, Senan S. Radiother Oncol; 2010 Dec 01; 97(3):437-42. PubMed ID: 21074878 [Abstract] [Full Text] [Related]
14. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. Widder J, Postmus D, Ubbels JF, Wiegman EM, Langendijk JA. Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e291-7. PubMed ID: 21640503 [Abstract] [Full Text] [Related]
19. Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning. Fritz P, Kraus HJ, Blaschke T, Mühlnickel W, Strauch K, Engel-Riedel W, Chemaissani A, Stoelben E. Lung Cancer; 2008 May 15; 60(2):193-9. PubMed ID: 18045732 [Abstract] [Full Text] [Related]
20. Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis. Fleckenstein J, Eschler A, Kremp K, Kremp S, Rübe C. Radiat Oncol; 2015 Aug 21; 10():178. PubMed ID: 26292716 [Abstract] [Full Text] [Related] Page: [Next] [New Search]